Health care-associated infections declined in 2010

Despite successes, more work is needed to ensure safe care and eliminate health care-associated infections

 

Atlanta, GA, USA (October 19, 2011) – Four common infections seen in health care facilities declined in 2010, according to the Centers for Disease Control and Prevention.  In a policy summit at the National Journal in Washington D.C., CDC staff detailed the reductions that are occurring in infection rates in U.S. hospitals. “Hospitals continue to make impressive progress in driving down certain infections in intensive care units through implementation of CDC prevention strategies,” said CDC Director Thomas R. Frieden, M.D., M.P.H. “Hospitals and state health departments need to translate this progress to other areas of health care delivery and health care infections, such as dialysis and ambulatory surgery centers, and diarrheal infections such as Clostridium difficile.”

The data were submitted by hospitals to the National Healthcare Safety Network, CDC’s health care infection monitoring system.  The number of infections reported was compared to a national baseline.  All of the infections reported have national prevention target goals as defined in the U.S. Department of Health and Human Services’ Action Plan to Prevent Healthcare-Associated Infections.

 

CDC reported for 2010:

 

  • A 33 percent reduction in central line-associated bloodstream infections: a 35 percent reduction among critical care patients and a 26 percent reduction among non-critical care patients. A central line is a tube that is placed in a large vein of a patient’s neck or chest to give important medical treatment. When not put in correctly or kept clean, central lines can become a freeway for germs to enter the body and cause serious bloodstream infections.
  • A 7 percent reduction in catheter-associated urinary tract infections throughout hospitals
  • A 10 percent reduction in surgical site infections
  • An 18 percent reduction in the number of people developing health care-associated invasive methicillin resistant Staphylococcus aureus (MRSA) infections

 

In addition, CDC saw improvement in health care provider adherence to proven infection prevention measures, such as appropriate techniques for inserting central line catheters into patients (over 94 percent adherence).  Two additional infections are currently being tracked, Clostridium difficile infections and MRSA bloodstream infections, and data on these infections will be available next year. 

 

“These successes reflect investments not only in hospital practices, but in our national and state public health capacity,” said Denise Cardo, M.D., director of CDC’s Division of Healthcare Quality Promotion.  “Preventing infections in health care saves lives and reduces health care costs.”

 

CDC has a unique role in the prevention of healthcare-associated infections in the United States. 

 

  • CDC responds to disease outbreaks in health care settings, providing health care facilities and states with resources to prevent future incidents.
  • CDC laboratories provide gold-standard testing of existing and emerging infectious threats to health care.
  • CDC guidelines are used by clinicians to prevent health care-associated infections; they form the basis for useful checklists to improve care.
  • CDC tracks health care-associated infections through the National Healthcare Safety Network, providing real-time data at the local, state, and national levels.

 

CDC supports the Partnership for Patients initiative, focused on protecting patients in America’s health care facilities through the prevention of health care-acquired conditions.  Federal initiatives, including Partnership for Patients and the HHS Action Plan to Prevent Healthcare-Associated Infections, aim to accelerate the prevention progress happening throughout the country.

 

The National Journal policy summit, titled “Spreading Success: Encouraging Best Practices in Infection Prevention” was held on Oct. 19 in Washington, D.C., and hosted by the Association for Professionals in Infection Control and Epidemiology (www.apic.org)

 

For a detailed summary of the infection data reported by CDC, please see the HHS website: http://www.hhs.gov/ash/initiatives/hai/nationaltargets/index.html

 


 

Centers for Disease Control and Prevention, 19.10.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…